Vaxcyte Inc (PCVX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering PCVX.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 4 | $55 | $42 | $48.25 | $18.67 | 158.44% |
The Trend in the Analyst Price Target
PCVX's average price target has moved down $1.5 over the prior 91 days.
Over the past 176 days, PCVX's average upside potential has been 99.28%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-05-08 | 4 | 55 | 42 | 48.25 | 17.64 | 173.53% |
| 2021-04-25 | 4 | 55 | 42 | 48.25 | 18.97 | 154.35% |
| 2021-04-17 | 4 | 55 | 42 | 48.25 | 18.22 | 164.82% |
| 2021-04-10 | 4 | 55 | 42 | 48.25 | 20.22 | 138.63% |
| 2021-04-03 | 4 | 55 | 42 | 48.25 | 20.93 | 130.53% |
| 2021-03-20 | 4 | 55 | 45 | 49.75 | 25.41 | 95.79% |
| 2021-03-13 | 4 | 55 | 45 | 49.75 | 26.38 | 88.59% |
| 2021-03-06 | 4 | 55 | 45 | 49.75 | 23.76 | 109.39% |
| 2021-02-27 | 4 | 55 | 45 | 49.75 | 23.56 | 111.16% |
| 2021-02-20 | 4 | 55 | 45 | 49.75 | 25.82 | 92.68% |
| 2021-02-13 | 4 | 55 | 45 | 49.75 | 26.17 | 90.1% |
| 2021-02-06 | 4 | 55 | 45 | 49.75 | 24.04 | 106.95% |
| 2021-01-30 | 4 | 55 | 45 | 49.75 | 24.53 | 102.81% |
| 2021-01-23 | 4 | 55 | 45 | 49.75 | 25.14 | 97.89% |
| 2021-01-16 | 4 | 55 | 45 | 49.75 | 25.70 | 93.58% |
| 2021-01-09 | 4 | 55 | 45 | 49.75 | 26.21 | 89.81% |
| 2021-01-02 | 4 | 55 | 45 | 49.75 | 26.57 | 87.24% |
| 2020-12-26 | 4 | 55 | 45 | 49.75 | 27.96 | 77.93% |
| 2020-12-19 | 4 | 55 | 45 | 49.75 | 30.51 | 63.06% |
| 2020-12-10 | 4 | 55 | 45 | 49.75 | 26.99 | 84.33% |
| 2020-12-07 | 4 | 55 | 45 | 49.75 | 31.96 | 55.66% |
| 2020-11-28 | 4 | 55 | 45 | 49.75 | 34.64 | 43.62% |
| 2020-11-13 | 4 | 55 | 45 | 49.75 | 38.00 | 30.92% |
PCVX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.3 | 2 | 3 | 0 | 0 | 0 | 5 |
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- PCVX has a greater upside potential (average analyst target price relative to current price) than 88.7% of all US stocks.
- PCVX has a higher number of analysts covering the stock than 20.28% of stocks in the mid market cap category.
- The average analyst price target of PCVX is greater than 75.47% of Pharmaceutical Products stocks.
- The variance in analysts' estimates of PCVX is less than 67.59% of Pharmaceutical Products stocks.
Stocks similar to Vaxcyte Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are FUSN, SRRK and FBRX.
Make investment decisions regarding PCVX using the data that counts. Try POWR Ratings for free.